These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 11706061)
1. Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC). Dalakas MC; Semino-Mora C; Leon-Monzon M Lab Invest; 2001 Nov; 81(11):1537-44. PubMed ID: 11706061 [TBL] [Abstract][Full Text] [Related]
2. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity. Anderson TD; Davidovich A; Feldman D; Sprinkle TJ; Arezzo J; Brosnan C; Calderon RO; Fossom LH; DeVries JT; DeVries GH Lab Invest; 1994 May; 70(5):724-39. PubMed ID: 7515130 [TBL] [Abstract][Full Text] [Related]
3. Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues. Famularo G; Moretti S; Marcellini S; Trinchieri V; Tzantzoglou S; Santini G; Longo A; De Simone C AIDS; 1997 Feb; 11(2):185-90. PubMed ID: 9030365 [TBL] [Abstract][Full Text] [Related]
4. Schwann cell mitochondrial alterations in peripheral nerves of rabbits treated with 2',3'-dideoxycytidine. Feldman D; Anderson TD Acta Neuropathol; 1994; 87(1):71-80. PubMed ID: 8140896 [TBL] [Abstract][Full Text] [Related]
5. Peripheral neuropathy and antiretroviral drugs. Dalakas MC J Peripher Nerv Syst; 2001 Mar; 6(1):14-20. PubMed ID: 11293802 [TBL] [Abstract][Full Text] [Related]
6. The antiretroviral 2',3'-dideoxycytidine causes mitochondrial dysfunction in proliferating and differentiated HepaRG human cell cultures. Young CKJ; Wheeler JH; Rahman MM; Young MJ J Biol Chem; 2021; 296():100206. PubMed ID: 33334881 [TBL] [Abstract][Full Text] [Related]
8. Peripheral neuropathy induced by 2',3'-dideoxycytidine. A rabbit model of 2',3'-dideoxycytidine neurotoxicity. Anderson TD; Davidovich A; Arceo R; Brosnan C; Arezzo J; Schaumburg H Lab Invest; 1992 Jan; 66(1):63-74. PubMed ID: 1309930 [TBL] [Abstract][Full Text] [Related]
9. Ultrastructure of peripheral neuropathy induced in rabbits by 2',3'-dideoxycytidine. Feldman D; Brosnan C; Anderson TD Lab Invest; 1992 Jan; 66(1):75-85. PubMed ID: 1309931 [TBL] [Abstract][Full Text] [Related]
10. Anti-human immunodeficiency virus type 1 therapy and peripheral neuropathy: prevention of 2',3'-dideoxycytidine toxicity in PC12 cells, a neuronal model, by uridine and pyruvate. Keilbaugh SA; Hobbs GA; Simpson MV Mol Pharmacol; 1993 Oct; 44(4):702-6. PubMed ID: 8232219 [TBL] [Abstract][Full Text] [Related]
11. Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs. Feng JY; Johnson AA; Johnson KA; Anderson KS J Biol Chem; 2001 Jun; 276(26):23832-7. PubMed ID: 11328813 [TBL] [Abstract][Full Text] [Related]
12. Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2',3'-dideoxycytidine (ddC). Dubinsky RM; Yarchoan R; Dalakas M; Broder S Muscle Nerve; 1989 Oct; 12(10):856-60. PubMed ID: 2558314 [TBL] [Abstract][Full Text] [Related]
13. Increased mitochondrial DNA copy-number in CEM cells resistant to delayed toxicity of 2',3'-dideoxycytidine. Bjerke M; Franco M; Johansson M; Balzarini J; Karlsson A Biochem Pharmacol; 2008 Mar; 75(6):1313-21. PubMed ID: 18206854 [TBL] [Abstract][Full Text] [Related]
14. 2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Berger AR; Arezzo JC; Schaumburg HH; Skowron G; Merigan T; Bozzette S; Richman D; Soo W Neurology; 1993 Feb; 43(2):358-62. PubMed ID: 8382349 [TBL] [Abstract][Full Text] [Related]
15. Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex. Skowron G; Bozzette SA; Lim L; Pettinelli CB; Schaumburg HH; Arezzo J; Fischl MA; Powderly WG; Gocke DJ; Richman DD; Pottage JC; Antoniskis D; McKinley GF; Hyslop NE; Ray G; Simon G; Reed N; LoFaro ML; Uttamchandani RB; Gelb LD; Sperber SJ; Murphy RL; Leedom JM; Grieco MH; Zachary J; Hirsch MS; Spector SA; Bigley J; Soo W; Merigan TC Ann Intern Med; 1993 Mar; 118(5):321-30. PubMed ID: 8094279 [TBL] [Abstract][Full Text] [Related]
16. Quantitation of blood lymphocyte mitochondrial DNA for the monitoring of antiretroviral drug-induced mitochondrial DNA depletion. Petit C; Mathez D; Barthélémy C; Leste-Lasserre T; Naviaux RK; Sonigo P; Leibowitch J J Acquir Immune Defic Syndr; 2003 Aug; 33(4):461-9. PubMed ID: 12869834 [TBL] [Abstract][Full Text] [Related]
17. Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells. Benbrik E; Chariot P; Bonavaud S; Ammi-Saïd M; Frisdal E; Rey C; Gherardi R; Barlovatz-Meimon G J Neurol Sci; 1997 Jul; 149(1):19-25. PubMed ID: 9168161 [TBL] [Abstract][Full Text] [Related]
18. Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat. Joseph EK; Chen X; Khasar SG; Levine JD Pain; 2004 Jan; 107(1-2):147-58. PubMed ID: 14715401 [TBL] [Abstract][Full Text] [Related]
19. Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitors. Reiss P; Casula M; de Ronde A; Weverling GJ; Goudsmit J; Lange JM HIV Med; 2004 Jan; 5(1):11-4. PubMed ID: 14731163 [TBL] [Abstract][Full Text] [Related]
20. The role of cytoplasmic deoxycytidine kinase in the mitochondrial effects of the anti-human immunodeficiency virus compound, 2',3'-dideoxycytidine. Chen CH; Cheng YC J Biol Chem; 1992 Feb; 267(5):2856-9. PubMed ID: 1310674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]